update special charectors

Signed-off-by: Hongxin Zhang <[email protected]>

Author: zhx828

app/scripts/controllers/news.js

@@ -42,28 +42,28 @@ angular.module('oncokbStaticApp')
             },
             '04052017': {
                 'Level 1': [
-                    'BRCA1/2 – Oncogenic Mutations – Ovarian Cancer – Niraparib FDA approval added',
-                    'BRCA1/2 – Oncogenic Mutations – Ovarian Cancer - Rucaparib (<b>new publication added</b>)',
+                    'BRCA1/2 - Oncogenic Mutations - Ovarian Cancer - Niraparib FDA approval added',
+                    'BRCA1/2 - Oncogenic Mutations - Ovarian Cancer - Rucaparib (<b>new publication added</b>)',
                     'Updated alterations for KIT - Gastrointestinal Stromal Tumor - Imatinib, Sunitinib, Regorafenib'
                 ],
                 'Level 2': [
-                    'Updated alterations for KIT - Gastrointestinal Stromal Tumor – Nilotinib, Dasatinib, Sorafenib',
-                    'Updated alterations for KIT – Thymic cancer – Sunitinib, Sorafenib'
+                    'Updated alterations for KIT - Gastrointestinal Stromal Tumor - Nilotinib, Dasatinib, Sorafenib',
+                    'Updated alterations for KIT - Thymic cancer - Sunitinib, Sorafenib'
                 ],
                 'Level 3': [
-                    'BRAF V600 – Colorectal Cancer - Encorafenib + Binimetinib + Cetuximab (<b>new association</b>)',
-                    'FGFR1 – Amplification – Lung Squamous Cell Carcinoma – AZD4547, Debio1347 (<b>new abstract added</b>)',
-                    'FGFR2 - Fusions – Cholangiocarcinoma – BGJ398, Debio1347 (<b>new abstract added</b>)',
-                    'Updated alterations for FGFR3 – Bladder cancer - JNJ-42756493, Debio1347',
-                    'PIK3CA – Oncogenic mutations – Breast cancer – Updated treatments and evidence'
+                    'BRAF V600 - Colorectal Cancer - Encorafenib + Binimetinib + Cetuximab (<b>new association</b>)',
+                    'FGFR1 - Amplification - Lung Squamous Cell Carcinoma - AZD4547, Debio1347 (<b>new abstract added</b>)',
+                    'FGFR2 - Fusions - Cholangiocarcinoma - BGJ398, Debio1347 (<b>new abstract added</b>)',
+                    'Updated alterations for FGFR3 - Bladder cancer - JNJ-42756493, Debio1347',
+                    'PIK3CA - Oncogenic mutations - Breast cancer - Updated treatments and evidence'
                 ],
                 'Level 4': [
-                    'BRAF V600 – Colorectal Cancer - Radiation + Trametinib + Fluorouracil (<b>new association</b>)',
-                    'Updated alterations for FGFR3 – Breast cancer - Debio1347',
-                    'KRAS – Wildtype – Updated treatments and evidence',
-                    'KRAS – Oncogenic mtuations - Updated treatments and evidence',
-                    'PIK3CA – Oncogenic mutations – Breast cancer – Updated treatments and evidence',
-                    'PTEN – Oncogenic mutations – Breast cancer – Updated treatments and evidence'
+                    'BRAF V600 - Colorectal Cancer - Radiation + Trametinib + Fluorouracil (<b>new association</b>)',
+                    'Updated alterations for FGFR3 - Breast cancer - Debio1347',
+                    'KRAS - Wildtype - Updated treatments and evidence',
+                    'KRAS - Oncogenic mtuations - Updated treatments and evidence',
+                    'PIK3CA - Oncogenic mutations - Breast cancer - Updated treatments and evidence',
+                    'PTEN - Oncogenic mutations - Breast cancer - Updated treatments and evidence'
                 ]
             },
             '02022018': {